Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Baldness (androgenic alopecia) could be a risk factor for prostate cancer.

Androgen receptor overexpression can increase prostate cancer cell growth even without hormones.

Prostate cancer screening doesn't significantly reduce death rates and has risks like overdiagnosis and side effects.

Higher cholesterol levels increase aggressive prostate cancer risk.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Male pattern baldness may predict prostate cancer risk.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Prostate cancer risk is not linked to blood testosterone levels.

Finasteride's effects on prostate cancer are not clear from this text.

Male pattern baldness may be linked to prostate cancer risk.

Finasteride treats hair loss and reduces prostate cancer risk.

Hair loss at the top of the head is linked to prostate cancer, but other types of hair loss are not.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Dutasteride may help shrink prostate cancer tumors.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Finasteride may help prevent prostate cancer.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Seven new genetic risk areas for prostate cancer were found.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Serum triglyceride levels are not linked to prostate cancer risk.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.